Showing results (1531-1540 of 1,699) with videos related to

Sort By:
Pageof 170
Physical Review Letters|February 9, 2019
Stellarators Resist Turbulent Transport on the Electron Larmor ScaleG G Plunk, P Xanthopoulos, G M Weir, et al.
International Journal of Cancer|April 1, 2026
Globo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancerKeren Zohar, Marco Strecker, Thomas Wartmann, et al.
Frontiers in Immunology|August 14, 2018
β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids <i>via</i> Farnesoid X Receptor and Constitutive Androstane ReceptorThomas Klag, Maria Thomas, Dirk Ehmann, et al.
Depression and Anxiety|December 6, 2018
Developmental changes in resting-state functional networks among individuals with and without internalizing psychopathologiesKatie L Burkhouse, Jonathan P Stange, Rachel H Jacobs, et al.
London Journal of Primary Care|March 3, 2017
Promoting Mental Health and Preventing Mental Illness in General PracticeSteve Thomas, Rachel Jenkins, Tony Burch, et al.
Journal of Crohn'S & Colitis|October 20, 2012
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE studyK R Herrlinger, M Diculescu, K Fellermann, et al.
Bulletin of the World Health Organization|July 1, 2026
Systemic path to global health 2050Joachim Sturmberg, Maru Mormina, Holger Pfaff, et al.
Journal of Psychiatric Research|June 23, 2022
Increased sensitivity of insula to supraliminal faces in adults with histories of mood disorders and self-injuryMelinda Westlund Schreiner, Alina K Dillahunt, Summer B Frandsen, et al.
Physical Review Letters|November 7, 2025
Stable Small Plasmas at the Density Limit in the W7-X StellaratorA Pandey, T S Pedersen, G Fuchert, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
Pageof 170